Document is current
Any future updates will be listed below
-
Authors
Senftleber, Ninna Karsbæk https://orcid.org/0000-0001-6619-1549
Andersen, Mette K. https://orcid.org/0000-0001-8227-1469
Jørsboe, Emil https://orcid.org/0000-0002-0593-7906
Stæger, Frederik Filip https://orcid.org/0000-0002-2295-8637
Nøhr, Anne Krogh
Garcia-Erill, Genis https://orcid.org/0000-0003-3150-1708
Meisner, Jonas
Santander, Cindy G. https://orcid.org/0000-0003-3021-6809
Balboa, Renzo F. https://orcid.org/0000-0003-2821-8020
Gilly, Arthur
Bjerregaard, Peter
Larsen, Christina Viskum Lytken
Grarup, Niels https://orcid.org/0000-0001-5526-1070
Jørgensen, Marit Eika
Zeggini, Eleftheria https://orcid.org/0000-0003-4238-659X
Moltke, Ida https://orcid.org/0000-0001-7052-8554
Hansen, Torben https://orcid.org/0000-0001-8748-3831
Albrechtsen, Anders https://orcid.org/0000-0001-7306-031X
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17OC0028136)
Novo Nordisk Fonden (NNF17SH0027192)
Novo Nordisk Fonden (NNF20OC0061343)
Novo Nordisk Fonden (NNF20OC0061343)
Novo Nordisk Fonden (NNF16OC0019986)
Novo Nordisk Fonden (NNF18CC0034900)
Novo Nordisk Fonden (NNF20OC0061343)
Det Frie Forskningsråd (DFF-0135-00211B)
Karen Elise Jensens Fond
Department of Health, Greenland
Københavns Universitet
AstraZeneca
Amgen
Boehringer Ingelheim
Novo Nordisk
Sanofi Aventis
Villum Fonden (19114)
- License Information
-
More Information
Article History
Received: 27 February 2023
Revised: 14 September 2023
Accepted: 11 October 2023
First Online: 30 October 2023
Competing interests
: The authors declare no competing interests.
: The study was approved by the Commission for Scientific Research in Greenland (project 2011–13, ref. no. 2011–056978; project 2013–13, ref.no. 2013–090702; and project 2012-16/17, ref.no. 2017-12997) and was conducted in accordance with the ethical standards of the Declaration of Helsinki, second revision. All participants gave informed consent.
